Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Retained Earnings (2009 - 2026)

Charles River Laboratories International (CRL) posted Retained Earnings of $1.4 billion for Q2 2026, little changed on a QoQ basis from $1.4 billion in Q1 2026, and down 27.39% year-over-year from $1.9 billion in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Retained Earnings (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Retained Earnings for 18 years, with the latest figure at $1.4 billion in Q2 2026.

  • On a quarterly basis, Retained Earnings fell 27.39% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 27.39% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 23.37% from the prior year.
  • Retained Earnings was $1.4 billion for Q2 2026 at Charles River Laboratories International, roughly flat from $1.4 billion in the prior quarter.
  • The five-year high for Retained Earnings was $2.1 billion in Q3 2024, with the low at $1.1 billion in Q1 2022.
  • Average Retained Earnings over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Retained Earnings jumped 56.31% in 2022, then declined 27.39% in 2026.
  • Over 5 years, Retained Earnings stood at $1.4 billion in 2022, then surged by 31.71% to $1.9 billion in 2023, then retreated by 3.98% to $1.8 billion in 2024, then fell by 23.37% to $1.4 billion in 2025, then decreased by 1.18% to $1.4 billion in 2026.
  • The last three Retained Earnings figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 7.96 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -511.37 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 2.30 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 1.37 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 2.14 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 1.71 Bn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 6.70 Bn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -81.50 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -106.74 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -357.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 1.37 Bn
Mar 28, 2026 1.37 Bn
Dec 27, 2025 1.39 Bn
Sep 27, 2025 1.94 Bn
Jun 28, 2025 1.89 Bn
Mar 29, 2025 1.84 Bn
Dec 28, 2024 1.81 Bn
Sep 28, 2024 2.12 Bn
Jun 29, 2024 2.05 Bn
Mar 30, 2024 1.96 Bn
Dec 30, 2023 1.89 Bn
Sep 30, 2023 1.72 Bn
Jul 1, 2023 1.63 Bn
Apr 1, 2023 1.54 Bn
Dec 31, 2022 1.43 Bn
Sep 24, 2022 1.28 Bn
Jun 25, 2022 1.18 Bn
Mar 26, 2022 1.07 Bn
Dec 25, 2021 980.75 Mn
Sep 25, 2021 878.82 Mn